Skip to Main Content

Paper Details

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
Clin Infect Dis
16
2023
Influenza, Influenza A(H3N2)-Related Illness, SARS, SARS-CoV, acute illness, acute respiratory illness, coronavirus disease, cough, influenza, influenza A(, influenza A(H3N2), participants, patients, persons, severe, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Brendan FlanneryNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
Helen K B TalbotVanderbilt University Medical Center
Carlos G GrijalvaVanderbilt University Medical Center
Karen J WernliKaiser Permanente Washington Health Research Institute
Karen J WernliKaiser Permanente Washington Health Research Institute
Arnold S MontoUniversity of Michigan School of Public Health ann arbor
Emily T MartinUniversity of Michigan School of Public Health ann arbor
Edward A BelongiaMarshfield Clinic Research Institute
Huong Q McLeanMarshfield Clinic Research Institute
Manjusha Gaglani
Manjusha GaglaniTexas A&M University College of Medicine
  • 1 - 11

Datasets

Release 1.2